Hepatitis C Drug Raises Cure Rate in a Late Trial

Wednesday, May 26, 2010 - 08:40 in Health & Medicine

About three-quarters of the patients who got a standard dose of the Vertex Pharmaceuticals drug in combination with the current existing treatment were essentially cured.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net